Søren Vraa

Søren Vraa is a physician and researcher affiliated with Aalborg University Hospital under the Faculty of Medicine, Department of Cardiology. His work bridges clinical practice and research, focusing on heart failure, cardiomyopathy, and diabetes-related cardiovascular complications. He actively collaborates on multicenter trials and has contributed to peer-reviewed publications.

• Heart Failure Pathophysiology
• Medical Imaging Applications
• Clinical Trial Design
• Diabetes-Cardiology Interface
• Interventional Procedures (Thoracentesis)

Vraa's research output includes pivotal studies like the DANHEART trial (2021) on hydralazine-isosorbide dinitrate and metformin in heart failure patients with diabetes, and the TAP-IT trial (2024) evaluating thoracentesis in acute heart failure. His work emphasizes evidence-based interventions and long-term outcome analysis.

He participates in professional organizations such as Dansk Cardiologisk Selskab and contributes to academic discourse through conference attendance (e.g., Euroecho, ESH). Media coverage of his work highlights its public relevance, particularly in heart failure management and biomarker utilization.